The European Commission's antitrust body said Friday it has cleared U.S. technology firm Danaher Corp. (DHR) to buy medical testing company Beckman Coulter (BEC).

The Commission concluded that the merged entity would continue to have significant rivals in the fields it covers and therefore the deal wouldn't harm competition in the European Union.

-By Laurence Norman, Dow Jones Newswires; 32-2741-1481; laurence.norman@dowjones.com

Beckman Coulter (NYSE:BEC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Beckman Coulter Charts.
Beckman Coulter (NYSE:BEC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Beckman Coulter Charts.